HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The use of CD31 and collagen IV as vascular markers. A study of 56 vascular lesions.

Abstract
A monoclonal antibody against the endothelial cell adhesion molecule CD31 (endo-CAM, PECAM-1) was tested on wax embedded tissue of 56 cases of vascular lesions including benign and malignant vascular neoplasms. Additional preparations were stained with antibodies to type IV collagen and to von Willebrand factor/Factor VIII-RAG (vWf). Our results prove reliability of CD31 and its superiority to vWf in the labelling of endothelium and its subsets in such lesions, with the exception of lymphangiomas. As markers for basal lamina collagen and endothelium respectively, type IV collagen and CD31 together provide a powerful tool for 1) the diagnosis of endothelial neoplasms and 2) the definition of endothelial, mural and pericytic or perivascular tissue compartments in vascular lesions of complex architecture. Hence, we use CD31 and type IV collagen in cases of presumed vascular neoplasms, adding other markers to the panel in accordance with the differential diagnosis, as well as in the recognition of compromised endothelia, such as in vascular invasion by various malignant neoplasms.
AuthorsD Schmidt, A R von Hochstetter
JournalPathology, research and practice (Pathol Res Pract) Vol. 191 Issue 5 Pg. 410-4 (Jun 1995) ISSN: 0344-0338 [Print] Germany
PMID7479359 (Publication Type: Journal Article)
Chemical References
  • Antigens, Differentiation, Myelomonocytic
  • Biomarkers, Tumor
  • Cell Adhesion Molecules
  • Platelet Endothelial Cell Adhesion Molecule-1
  • von Willebrand Factor
  • Collagen
Topics
  • Antigens, Differentiation, Myelomonocytic (analysis)
  • Biomarkers, Tumor (analysis)
  • Cell Adhesion Molecules (analysis)
  • Cell Compartmentation
  • Collagen (analysis, immunology)
  • Diagnosis, Differential
  • Endothelium, Vascular (chemistry)
  • Humans
  • Platelet Endothelial Cell Adhesion Molecule-1
  • Vascular Neoplasms (chemistry, pathology)
  • von Willebrand Factor (analysis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: